Deloitte Legal advises on the sale of FairJourney Biologics
Deloitte Legal Portugal advised FairJourney Biologics, a Portuguese biotechnology company specialized in the healthcare sector, on the sale of their entire share capital to Partners Group. FairJourney will have Partners Group, one of the world’s largest private equity funds, as its majority shareholder. Its founder and CEO, António Parada, and GHO Capital Partners LLP will remain in the shareholder structure with minority stakes.
The advisors’ team
The legal advisory was led by Miguel Koch Rua (pictured), a partner in Deloitte Legal’s Corporate and M&A department, responsible for the Porto office, with the support of associate Eduarda Alves da Costa and the Labor and TMT teams, led by Pedro Ulrich and Jacinto Moniz de Bettencourt, respectively.
